BANK OF AMERICA CORP /DE/ - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 72 filers reported holding HUMACYTE INC in Q3 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of HUMACYTE INC
ValueSharesWeighting
Q3 2023$156,972
+353.3%
53,574
+342.5%
0.00%
Q2 2023$34,626
-68.3%
12,107
-65.7%
0.00%
Q1 2023$109,136
-54.4%
35,319
-68.8%
0.00%
Q4 2022$239,177
+61.6%
113,354
+149.5%
0.00%
Q3 2022$148,000
-37.3%
45,427
-38.3%
0.00%
Q2 2022$236,000
+39.6%
73,666
+208.2%
0.00%
Q1 2022$169,000
+231.4%
23,904
+247.1%
0.00%
Q4 2021$51,000
+27.5%
6,887
+96.7%
0.00%
Q3 2021$40,0003,5020.00%
Other shareholders
HUMACYTE INC shareholders Q3 2022
NameSharesValueWeighting ↓
York Capital Management Global Advisors, LLC 2,291,397$16,613,0003.70%
Monashee Investment Management LLC 399,910$2,899,0000.72%
Endowment Wealth Management, Inc. 96,618$700,0000.71%
Gladstone Institutional Advisory LLC 246,717$1,7890.14%
Diameter Capital Partners LP 300,338$2,177,0000.13%
CenterBook Partners LP 23,706$172,0000.10%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 900,100$6,526,000,0000.06%
Exos Asset Management LLC 16,139$117,0000.06%
Maven Securities LTD 200,000$1,450,0000.04%
VALLEY FORGE INVESTMENT CONSULTANTS INC ADV 11,000$80,0000.04%
View complete list of HUMACYTE INC shareholders